Leucine

Leucine

SCHEMBL139231

CC(C)C[C@H](N)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Leucine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.55
SLC1A3 P43003 4/20 0.45
SLC1A2 P43004 4/20 0.45
SLC1A1 P43005 3/20 0.39
DPP4 P27487 3/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
NOS2 P35228 2/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
PRCP P42785 1/20 0.35
GRIK1 P39086 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA4 P48058 1/20 0.35
GRIK3 Q13003 1/20 0.35
GRIK5 Q16478 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucine SCHEMBL27191662 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL17113855 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL756553 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL29092653 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL756554 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
D-Leucine SCHEMBL1537225 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL139230 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL5060410 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL17113857 1.00 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL8817376 0.97 SLC7A5 (0.51) SLC7A5SLC1A3SLC1A2SLC1A1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3122902-A1 METHOD OF PREDICTING THE TUMOR RESPONSE TO DNA METHYLATION INHIBITORS AND ALTERNATIVE THERAPEUTIC REGIMEN FOR OVERCOMING RESISTANCE Palacký University In Olomouc (CZ) 2017-02-01 EP claimed
WO-2015144102-A1 METHOD OF PREDICTING THE TUMOR RESPONSE TO DNA METHYLATION INHIBITORS AND ALTERNATIVE THERAPEUTIC REGIMEN FOR OVERCOMING RESISTANCE PALACKY UNIVERSITY, OLOMOUC (CZ) 2015-10-01 WO claimed
EP-2900206-A2 USE OF A COMBINATION OF AT LEAST ONE POLYUNSATURATED FATTY ACID AND AT LEAST ONE CAROTENOID, FOR IMPROVING THE QUALITY OF THE NAILS Laboratoires Inneov (FR) 2015-08-05 EP claimed
US-20150208683-A1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION CONOPCO, INC., D/B/A UNILEVER (US) 2015-07-30 US claimed
EP-2897464-A1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION Unilever N.V. (NL) 2015-07-29 EP claimed
WO-2014044582-A1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION UNILEVER N.V. (NL) 2014-03-27 WO claimed
EP-2482678-B1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD (FI) 2013-07-10 EP claimed
EP-2482678-A1 CHEESE AND METHOD FOR ITS MANUFACTURING Valio Ltd. (FI) 2012-08-08 EP claimed
US-20120183644-A1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD. (FI) 2012-07-19 US claimed
WO-2011039414-A1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD (FI) 2011-04-07 WO claimed
EP-3122902-A1 METHOD OF PREDICTING THE TUMOR RESPONSE TO DNA METHYLATION INHIBITORS AND ALTERNATIVE THERAPEUTIC REGIMEN FOR OVERCOMING RESISTANCE Palacký University In Olomouc (CZ) 2017-02-01 EP disclosed
EP-2897464-B1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION UNILEVER NV (NL) 2015-12-09 EP disclosed
WO-2015144102-A1 METHOD OF PREDICTING THE TUMOR RESPONSE TO DNA METHYLATION INHIBITORS AND ALTERNATIVE THERAPEUTIC REGIMEN FOR OVERCOMING RESISTANCE PALACKY UNIVERSITY, OLOMOUC (CZ) 2015-10-01 WO disclosed
EP-2900205-A2 USE OF A COMBINATION OF TAURINE OR A DERIVATE THEREOF AND A GRAPE EXTRACT FOR IMPROVING THE QUALITY OF THE NAILS Laboratoires Inneov (FR) 2015-08-05 EP disclosed
US-20150208683-A1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION CONOPCO, INC., D/B/A UNILEVER (US) 2015-07-30 US disclosed
US-20100022747-A1 PROPHYLACTIC AGENT FOR HEART FAILURE CALPIS CO., LTD. (JP) 2010-01-28 US disclosed
US-20100022748-A1 PROPHYLACTIC AGENT FOR RENAL FAILURE CALPIS CO., LTD. (JP) 2010-01-28 US disclosed
EP-2138184-A1 PROPHYLACTIC AGENT FOR RENAL FAILURE Calpis Co., Ltd. (JP) 2009-12-30 EP disclosed
EP-2130546-A1 PROPHYLACTIC AGENT FOR HEART FAILURE Calpis Co., Ltd. (JP) 2009-12-09 EP disclosed
US-20090298773-A1 METHODS OF PRODUCING FUNCTIONAL MISO MARUKOME CO., LTD. (JP) 2009-12-03 US disclosed